Atlas Trials

Gabapentin for the Reduction of Radiation Therapy Induced Pain During the Treatment of Oropharyngeal Cancer

Clinical trial NCT03269344 · COMPLETED

Trial details

NCT number
NCT03269344
Sponsor
Henry Ford Health System
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Oropharynx Cancer
Start date
2017-06-05
Primary completion
2020-12-09
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.